A pilot plasma-ctDNA ring trial for the Cobas® EGFR Mutation Test in clinical diagnostic laboratories

Aliki Ntzifa; Christos Kroupis; Alexander Haliassos; Evi Lianidou

doi:10.1515/cclm-2018-0676

A pilot plasma-ctDNA ring trial for the Cobas® EGFR Mutation Test in clinical diagnostic laboratories

Clin Chem Lab Med. 2019 Apr 24;57(5):e97-e101. doi: 10.1515/cclm-2018-0676.

Authors

Aliki Ntzifa¹, Christos Kroupis², Alexander Haliassos³, Evi Lianidou⁴

Affiliations

¹ Analysis of Circulating Tumor Cells, Lab of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Clinical Biochemistry and Molecular Diagnostics, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
³ ESEAP-Proficiency Testing Scheme for Clinical Laboratories, Athens, Greece.
⁴ Analysis of Circulating Tumor Cells, Lab of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Athens 15771, Greece.

PMID: 30267626
DOI: 10.1515/cclm-2018-0676

No abstract available

Keywords: circulating tumor DNA; epidermal growth factor receptor (EGFR) mutations; external quality assessment (EQA); liquid biopsy; non-small cell lung carcinoma (NSCLC).

Publication types

Letter
Multicenter Study

MeSH terms

Blood Chemical Analysis / methods
Circulating Tumor DNA / blood*
ErbB Receptors / genetics
Greece
Humans
Mutation
Pilot Projects
Reproducibility of Results

Substances

Circulating Tumor DNA
EGFR protein, human
ErbB Receptors